Low Sodium Oxybate as a Treatment for Nocturnal Cluster Headache

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

May 31, 2028

Conditions
Chronic Cluster Headache
Interventions
DRUG

Low Sodium Oxybate

Low sodium oxybate (LXB) will be administered as a twice nightly regimen. All subjects will undergo an 8 week Treatment Titration and Optimization Phase. Titration should proceed in an increment of 1.5g per night each 7 days until a 50% reduction in nocturnal headache frequency is achieved or a maximum dose (9g per night) is reached. If a subject is unable to titrate to a higher dose, they may stay at the highest tolerated dose for the duration of the study. Subjects may stop titration or have dose reduction at any time for safety and tolerability reasons.

DRUG

Placebo

Placebo with equal appearance

All Listed Sponsors
lead

Leiden University Medical Center

OTHER